Skip to main navigation
Skip to search
Skip to main content
The University of Brighton Home
Search content at The University of Brighton
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Student theses
Overlapping Impacts of HIV/COVID-19 Pandemic on HIV Vaccine Development
Seyi Samson Enitan
, Surajudeen Alim Junaid
,
Richard Yomi Akele
, Idris Nasir Abdullahi
, Grace Eleojo Itodo
, Esther Ngozi
, Chioma Jane Agunsoye Adejumo
, Chukwudi Amaechi Ofodile
, Ovye Engom Godiya Alaba
, Comfort Bosede Enitan
School of Applied Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Overlapping Impacts of HIV/COVID-19 Pandemic on HIV Vaccine Development'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Vaccine Development
100%
HIV Vaccine
100%
Coronavirus disease-19 Pandemic
100%
Overlapping Impact
100%
COVID-19
60%
Potential Exposure
40%
Clinic Staff
40%
Ethical Issues
20%
Neutralizing Antibodies
20%
Global Economy
20%
China
20%
Response Measures
20%
HIV Prevention
20%
Intervention Development
20%
Virus
20%
Megacity
20%
Global Health
20%
Lifesaving
20%
Infection Prevention
20%
Safety Concerns
20%
Vaccine Effectiveness
20%
Efficacy Trial
20%
New Coronavirus
20%
Rapid Test Kit
20%
Wuhan
20%
Novel Coronavirus
20%
Total Confirmed Cases
20%
Coronavirus disease-19 Outbreak
20%
Vaccine Safety
20%
Antibody Vaccines
20%
Safety Trial
20%
Stringent Response
20%
Mandatory Vaccines
20%
Vaccine Trial
20%
Pandemic Impact
20%
Total Death
20%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Coronavirinae
100%
Vaccine Development
100%
Human Immunodeficiency Virus Vaccine
100%
Diseases
100%
Volunteer
11%
DNA Template
11%
Infection
11%
Study Participant
11%
Rapid Test
11%
Global Health
11%
Neutralizing Antibody
11%
Pandemic
11%
Virus
11%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Coronavirinae
100%
Vaccine Development
100%
Human Immunodeficiency Virus Vaccine
100%
Diseases
100%
Infection
11%
Pandemic
11%
Neutralizing Antibody
11%
Virus
11%